Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency

INTRODUCTION: Standard treatment for patients with primary immunodeficiency (PID) is monthly intravenous immunoglobulin (IVIG), or weekly/biweekly subcutaneous immunoglobulin (SCIG) infusion. We used population pharmacokinetic modeling to predict immunoglobulin G (IgG) exposure following a broad ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidhu, Jagdev, Rojavin, Mikhail, Pfister, Marc, Edelman, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254869/
https://www.ncbi.nlm.nih.gov/pubmed/25118975
http://dx.doi.org/10.1007/s13554-014-0018-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254869/
https://www.ncbi.nlm.nih.gov/pubmed/25118975
http://dx.doi.org/10.1007/s13554-014-0018-0

Ejemplares similares